Cell kinetics and differentiation after hormonal-induced prostatic hyperplasia in the dog

Prostate

Volumn 44, Issue 1, 2000, Pages 40-48

  Mahapokai, Wanna ^a,b   Xue, Yong ^c   Van Garderen, Evert ^a   Van Sluijs, Frederik J ^a   Mol, Jan A ^a   Schalken, Jack A ^a,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b KHON KAEN UNIVERSITY   (Thailand)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Benign prostatic hyperplasia; Cell kinetics; Cytokeratins; Dog

Indexed keywords

ANDROSTANEDIOL; CYTOKERATIN; ESTRADIOL;

ADOLESCENT; AGED; AGING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASAL CELL; CASTRATION; CELL DIFFERENTIATION; CELL KINETICS; CONTROLLED STUDY; DOG; EXOCRINE CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY;

AGE FACTORS; ANABOLIC AGENTS; ANDROSTANE-3,17-DIOL; ANIMALS; ANTIBODIES, MONOCLONAL; BIOPSY; CELL DIVISION; DOGS; EPITHELIAL CELLS; ESTRADIOL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KERATINS; KINETICS; MALE; ORCHIECTOMY; PROSTATE; PROSTATIC HYPERPLASIA;

EID: 0034659706     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(20000615)44:1<40::AID-PROS6>3.0.CO;2-J     Document Type: Article

References (25)

1. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
2. Robinson EJ, Neal DE, Collins AT. Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate 1998;37:149-160.
3. kipl in normal, hyperplastic and neoplastic cells. Am J Pathol 1998; 153:911-919.
4. Reiter RE, Gu Z, Watabe T, Thomas G, Szigeti K, Davis E, Wahl M, Nisitani S, Yamashiro J, Le Beau MM, Loda M, Witte ON. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci USA 1998;95:1735-1740.
5. Bonkhoff H, Remberger K. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate 1996;28:98-106.
6. Bonkhoff H, Stein U, Remberger K. Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers. Hum Pathol 1994;25:42-46.
7. Walensky LD, Coffey DS, Chen TH, Wu TC, Pasternack GR. A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewal. Cancer Res 1993;53: 4720-4726.
8. Srigley JR, Dardick I, Hartwick RW, Klotz L. Basal epithelial cells of human prostate gland are not myoepithelial cells. A comparative immunohistochemical and ultrastructural study with the human salivary gland. Am J Pathol 1990;136:957-966.
9. Isaacs JT, Coffey DS. Etiology and disease process of benign prostatic hyperplasia. Prostate [Suppl] 1989;2:33-50.
10. Verhagen AP, Ramaeker FC, Aalders TW, Schaafsma HE, Debruyne FM, Schalken JA. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res 1992;52:6182-6187.
11. Bonkhoff H. Role of the basal cells in premalignant changes of the human prostate: a stem cell concept for the development of prostate cancer. Eur Urol 1996;30:201-205.
12. Xue Y, Smedts F, Umbas R, Aalders TW, Debruyne FMJ, de la Rosette JJMCH, Schalken JA. Changes in keratin expression during the development of benign prostatic hyperplasia (BPH). Eur Urol 1997;32:332-338.
13. Xue Y, Smedts F, Debruyne FMJ, de la Rosette JJMCH, Schalken JA. Identification of intermediate cell types by keratin expression in the developing human prostate. Prostate 1998;34:292-301.
14. Verhagen AP, Aalders TW, Ramaeker FC, Debruyne FM, Schalken JA. Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration. Prostate 1988;13:25-38.
15. Isaacs JT. Common characteristics of human and canine benign prostatic hyperplasia. Prog Clin Biol Res 1984;145:217-234.
16. Walsh PC, Wilson JD. The induction of prostatic hyperplasia in the dog with androstanediol. J Clin Invest 1976;57:1093-1097.
17. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LWK, Hsieh J, Tu S, Campbell ML. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 1992;52: 6940-6944.
18. Nickerson T, Pollak M, Huynh H. Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2, 3, 4 and 5. Endocrinology 1998;139:807-810.
19. Kyprianou N, Isaacs JT. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 1988;122: 552-562.
20. Lin T-M, Lustig RH, Chang C. The role of androgen-androgen receptor in immune system activity. In: Marsh JA, Kendall MD, editors. The physiology of immunity. New York: CRC Press; 1996. p 263-273.
21. Chapman JC, Despande R, Michael SD. Estrogen-mediated interactions between the immune and female reproduction systems. In: Marsh JA, Kendall MD, editors. The physiology of immunity. New York: CRC Press; 1996. p 239-253.
22. Helpap B. Pathologie der ableitenden Harnwege und der Prostata. Berlin, Heidelberg: Springer-Verlag; 1989. p 170.
23. Theyer G, Kramer G, Assmann I, Sherwood E, Preinfalk W, Marberger M, Zechner O, Steiner GE. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia. Lab Invest 1992;66:96-107.
24. Steiner G, Gessl A, Kramer G, Schöllhammer A, Förster O, Marberger M. Phenotye and function of peripheral and prostatic lymphocytes in patients with benign prostatic hyperplasia. J Urol 1994;151:480-484.
25. Pérez-Blas M, Martinez-Martin B, Carballido J, Hontoria J, Salazar LI, Olivier C, Alvarez-Mon M. Defective functional response to membrane stimuli in lymphocytes from patients with benign prostatic hyperplasia. Clin Exp Immunol 1995;101:521-526.